Author: Keith Ashcroft - Page 2

Fixed-dose combination drugs: what they are and why they exist

Keith Ashcroft
|
November 24
|
13

Fixed-dose combination drugs combine two or more medications in one pill to improve adherence, reduce pill burden, and enhance treatment effectiveness. Learn how they work, where they're used, and when they make sense.

Long-Acting Injectables: Why Extended Side Effect Monitoring Is Non-Negotiable

Keith Ashcroft
|
November 20
|
14

Long-acting injectable antipsychotics improve adherence but require rigorous, ongoing side effect monitoring to prevent serious physical health complications. Current practices fall dangerously short.

Hydration and Diuretics: How to Balance Fluid Intake to Avoid Side Effects

Keith Ashcroft
|
November 19
|
12

Learn how to balance fluid intake when taking diuretics to avoid dehydration, electrolyte loss, and dangerous side effects. Practical tips on water, electrolytes, weight tracking, and what to avoid.

The Environmental Impact of Tinidazole: What We Know So Far

Keith Ashcroft
|
November 18
|
14

Tinidazole, a common antibiotic, is polluting waterways and fueling antibiotic resistance. Learn how it enters the environment, its effects on wildlife, and what you can do to help.

Nausea Medications in Pregnancy: Safe Options and Real Risk Profiles

Keith Ashcroft
|
November 17
|
9

Safe and effective medications for pregnancy nausea, including ginger, B6, Diclegis, and antihistamines - and which ones to avoid due to birth defect risks like cerebral palsy and hypospadias.

Healthcare System Savings: How Generic Drugs Cut Billions in U.S. Drug Costs

Keith Ashcroft
|
November 9
|
12

Generic drugs saved the U.S. healthcare system $482 billion in 2024 by making up 90% of prescriptions but only 12% of spending. Biosimilars are the next frontier, with potential to cut $234 billion more - if we act.

Rumalaya Gel vs Alternatives: Which Topical Pain Relief Works Best?

Keith Ashcroft
|
November 1
|
15

Rumalaya Gel offers gentle, herbal pain relief for arthritis and muscle stiffness. Compare it to arnica, Biofreeze, and Voltaren to find the best topical option for your needs - without harsh chemicals or side effects.

Avandia (Rosiglitazone) vs Alternatives: What You Need to Know in 2025

Keith Ashcroft
|
October 28
|
12

Avandia (rosiglitazone) is rarely used today due to serious heart and bone risks. Discover safer, more effective alternatives like metformin, SGLT2 inhibitors, and GLP-1 agonists for type 2 diabetes management in 2025.

Donepezil’s Emerging Role for Treating Neurodegenerative Disorders Beyond Alzheimer’s

Keith Ashcroft
|
October 26
|
15

Explore how donepezil, long used for Alzheimer’s, may help treat Parkinson’s, Lewy body dementia, Huntington’s and other neurodegenerative disorders, with evidence, safety tips, and future trial updates.

Bisacodyl’s Role in Managing Functional Constipation - What You Need to Know

Keith Ashcroft
|
October 25
|
10

Learn how bisacodyl works, proper dosing, side effects, and when it’s best for treating functional constipation.